SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Cannabis > Lexaria Bioscience Corp. (LXRP)

LXRP's Breakthrough Lipid-Based Delivery System Revolutionizes Delivery of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NetworkNewsWire Member Profile
Member Level 
Followed By 19
Posts 1,989
Boards Moderated 20
Alias Born 10/18/16
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/26/2017 6:03:16 AM
Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects "NetworkNewsWire" - 9/19/2017 8:45:00 AM
Landmark M&A Deals Continue to Shape Big Pharma "NetworkNewsWire" - 9/6/2017 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/6/2017 6:02:26 AM
MJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investing "InvestorsHub NewsWire" - 8/30/2017 10:29:33 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/30/2017 2:53:01 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/28/2017 5:41:03 PM
PotNetwork Holdings, Inc Confirmed for MJAC 2017 "InvestorsHub NewsWire" - 8/28/2017 10:43:55 AM
MJAC 2017 International Cannabis Conference - Discount Code "InvestorsHub NewsWire" - 8/24/2017 8:40:00 AM
MJAC 2017 - Speaker Update - Investing In The U.S. Cannabis Market "InvestorsHub NewsWire" - 8/22/2017 1:27:13 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/18/2017 6:02:41 AM
FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators "NetworkNewsWire" - 8/16/2017 8:45:00 AM
Biotech Players Lead the Growth Charge in the Legal Cannabis Market "NetworkNewsWire" - 7/27/2017 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 6:03:19 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/19/2017 6:02:27 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 7/14/2017 6:02:47 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/23/2017 4:42:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/22/2017 7:23:56 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/8/2017 1:50:21 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/7/2017 12:19:54 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/2/2017 7:44:29 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/1/2017 6:03:36 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/26/2017 3:54:59 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/23/2017 5:17:59 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/12/2017 3:44:53 PM
NetworkNewsWire Member Level  Tuesday, 10/03/17 12:46:02 PM
Re: None
Post # of 17709 
Compensated Awareness Post - View Disclaimer
LXRP's Breakthrough Lipid-Based Delivery System Revolutionizes Delivery of Cannabinoids and More

Pioneering biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed a breakthrough lipid-based system that facilitates more efficient delivery of bioactive compounds—not only enhancing bio-absorption and bioavailability but also improving taste, smell and the onset of action. Lexaria intends to out-license this patented and proprietary technology, and the company has already applied this delivery technology to its line of products, which includes ViPova, Lexaria Energy and TurboCBD. An article further discussing this reads: “Lexaria’s novel technology, DehydraTECH™, ticks all these boxes by infusing the molecules of organically sourced hemp oil, high in cannabidiol (CBD), inside the molecules of lipids. Lipids seem a natural choice, since the human endocannabinoid system is itself lipid-based. Using them as a vehicle for delivering cannabinoids in curatives results in more absorption, less waste and, just as importantly, fewer side effects (http://nnw.fm/7Yuym). With DehydraTECH, a little hemp oil goes a long way, improving the healthful benefits and, of course, saving money.”

To view the full article, visit http://nnw.fm/yHk3L

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information about Lexaria, visit www.lexariabioscience.com.


\
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist